AN2 Therapeutics Statistics
NASDAQ: ANTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.08-0.14 (-2.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AN2 Therapeutics by the numbers
AN2 Therapeutics has a market capitalization of $192.8 million based on 37.94M shares outstanding. With trailing EPS of $-0.91, AN2 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.5% above its 50-day average and 17.7% above its 200-day average.
Average daily trading volume is 289.29K shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANTX valuation vs. peer median
| Metric | ANTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $192.75M | $197.61M | -2% |
| Avg. volume | 289.29K | 321.77K | -10% |
Peer median across 8 companies: ACIU, YARW, BIOA, RNAC, NGEN, DRUG, BCYC, FTH.
Valuation
- Market cap
- $192.75M
- EPS (TTM)
- $-0.91
- Shares outstanding
- 37.94M
Price and trading
- Previous close
- 5.22
- Open
- 5.13
- Day range
- 4.99 – 5.49
- 52-week range
- 1.00 – 7.19
- 52-week change
- +366.06%
- Beta
- —
- Volume
- 332.67K
- Average volume
- 289.29K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 192.75M
- Forward Pe
- -6.64
- Eps
- -0.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.19
- Week52 Low
- 1.00
- Avg Volume
- 289.29K
- Shares Outstanding
- 37.94M
- Ma50
- 4.51
- Ma200
- 4.32
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -29.35%
- Pct From52w Low
- 408.00%